Facet Biotech: Clinical Trials

6 trials sponsored by Facet Biotech, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 withdrawn. 6 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Completed 5, Withdrawn 1
Phase 24Completed 4

Follow Facet Biotech: new trials by email

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I, Multi-Center, Open-Label, Dose Escalation Study of HuLuc63 in Subjects With Advanced Multiple Myeloma
HuLuc63 - Multiple Myeloma
Phase 1CompletedFacet Biotech352006-12-012009-09-23
Ulcerative Colitis Study: Study of Visilizumab in Patients With Severe Ulcerative Colitis
Visilizumab - Severe Ulcerative Colitis
Phase 1 / Phase 2CompletedFacet Biotech1442004-01-012012-03-09
Research Study of Visilizumab for Treatment of Acute Graft Versus Host Disease
Visilizumab - Graft vs Host Disease
Phase 1 / Phase 2CompletedFacet Biotech342002-03-012012-03-13
To Study the Use of Humanized CD25 in Preventing the Relapse of Psoriasis Vulgaris
Daclizumab, NB-UVB - Psoriasis
Phase 1 / Phase 2CompletedRockefeller University61997-10-012009-03-25
To Study the Effects of CD25 and Low Dose Cyclosporin in the Treatment of Active Psoriasis Vulgaris
Daclizumab, Cyclosporine, cyclosporine and Daclizumab - Psoriasis
Phase 1 / Phase 2CompletedRockefeller University201997-10-012009-03-13
A Study of Ularitide in the Treatment of Subjects With Acute Decompensated Heart Failure
Ularitide - Heart Failure, Congestive
Phase 1WithdrawnFacet Biotech322009-07-20

Conditions studied

Psoriasis (2)  ·  Colitis, Ulcerative (1)  ·  Graft vs Host Disease (1)  ·  Heart Failure (1)  ·  Multiple Myeloma (1)  ·  Neoplasms (1)

Interventions

Daclizumab (2)  ·  visilizumab (2)  ·  Cyclosporine (1)  ·  Ularitide (1)  ·  elotuzumab (1)

Countries

United States (6)

Top investigators

James Krueger, MD, PHD (2)  ·  Ann Mohrbacher, M.D. (1)  ·  Barry Greenberg, MD (1)  ·  Daniel Fuleihan, MD (1)  ·  Darshak Karia, MD (1)  ·  Elie Korban, MD (1)  ·  Frits van Rhee, M.D. (1)  ·  Gregory Ewald, MD (1)  ·  Jeffrey A. Zonder, M.D. (1)  ·  Nikhil Munshi, M.D. (1)  ·  Nirav Y. Raval, MD (1)  ·  Richard Nowak, MD (1)  ·  Robert Dean, MD (1)  ·  Samer Al-Homsi, M.D. (1)  ·  Seema Singhal, M.D. (1)

Results publications

PMID 19714757